Vertex Pharmaceuticals (VRTX) reachead $475.49 at the closing of the latest trading day, reflecting a -1.41% change compared to its last close.

Learn more about whether Alkami Technology, Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Vertex Pharmaceuticals Inc. closed 8.54% short of its 52-week high of $519.88, which the company achieved on November 8th.

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

The recent selloff has GreensKeeper excited about the price declines. Click here to read on to learn about our response to ...

FinTech Magazine rounds up the leading stories from the week in fintech, featuring AI strategies, new funding rounds and the ...

Cloud Next event might have been completely overshadowed by Trump’s announcements of a 90-day pause to his global ...

The HYPE token rose to a high of $14.95 on Friday, up by 60% from its lowest point this month as the Hyperliquid volume rises ...

U.S. President Donald Trump is shaking up the stock market— and how! Wall Street lost over $6 trillion last week thanks to his tariff bombshell, which triggered panic selling and prompted economists ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Western Midstream Partners L.P.-1.70% $13.92B ...